Cellulitishttps://en.wikipedia.org/wiki/Cellulitis
Cellulitis he mate huakita e pa ana ki nga papa o roto o te kiri. Hei tohu me nga tohu, ka piki te rahi o te waahi mamae o te whero i roto i nga ra torutoru. Ko nga taitapa o te waahi whero kaore i te tino tohuhia, ka pupuhi pea te kiri. Ko te waahi o te mate he mamae tonu. Kei te kirikaa me te māuiui (myalgia) te tangata.

Ko nga waewae me te kanohi nga waahi e tino kitea ana. Ko nga mea morearea ko te momona, te pupuhi o nga waewae, me te koroheketanga. Ko nga huakita e tino pa ana ko te streptococci me te Staphylococcus aureus.

Ko te tikanga ko te maimoatanga me nga paturopi ka tangohia e te mangai, penei i te cephalexin, amoxicillin, cloxacillin ranei. Tata ki te 95% o nga tangata ka pai ake i muri i te 7 ki te 10 ra o te maimoatanga. Ko te hunga e mate huka ana, he kino ake nga hua.

Ko te cellulitis he mate noa, a i roto i te United Kingdom, ko te cellulitis te take mo te 1.6% o te whakauru ki te hohipera. Ko te Cellulitis i te tau 2015 i mate tata ki te 16,900 nga mate puta noa i te ao.

Maimoatanga - Rongoa OTC
Ko te cellulitis matatau me maimoatanga me nga patu paturopi kua tohua e te taote anake. Mena ka tere haere te mate me te haere tahi me te kirikaa me te makariri, he mea tika kia kite wawe i te taote.
Ko te tono hinu paturopi i runga i te hoko-kore ki nga patunga moata ka awhina pea. Mena he angiangi rawa te tono o te hinu, kare pea e whai hua.
#Polysporin
#Bacitracin
#Betadine

Whakamahia nga rongoa mamae OTC penei i te acetaminophen hei whakamama i te mamae.
#Ibuprofen
#Naproxen
#Acetaminophen

Kia ma o waewae me te rongoa i te waewae o te kaipara hākinakina (athlete's foot) na te mea ka nui ake te mate o te cellulitis ma te waewae o te kaipara hākinakina (athlete's foot).

Maimoatanga
#First-generation cephalosporins (e.g. Cefradine)
#Bacterial culture
#Third-generation cephalosporins (e.g. Cefditoren Pivoxil)
☆ I te 2022 Stiftung Warentest hua mai i Tiamana, he iti noa iho te pai o nga kaihoko ki a ModelDerm i nga korero mo te waea rongoa utu.
  • He waahi noa te waewae mo Cellulitis.
  • Take angamaheni
  • Cellulitis – rongoā
  • Cellulitis i te waewae maui. Mena ka horapa whanui, ka puta te kirikaa nui, ka pa te mate o te mate.
  • Ina pai ake te whiu, ka puta pea te hyperpigmentation i muri i te mumura.
  • Na te marutanga o te nikau ka puta.
  • Take angamaheni
  • Ki te papaki whero (erythematous) tere, māuiui, me te whakawhāiti (swelling), me whakapae Cellulitis.
  • Ka pai ake te Cellulitis, ka tihorea nga kiri mate (skin infection), ka tihorea.
  • Ko te nuinga o te Cellulitis ka haere tahi me te pupuhi me te erythema o te rohe. Heoi, i roto i tēnei case (case) motuhake kāore he erythema huri noa, me whakapae anō hoki te squamous cell carcinoma (squamous cell carcinoma).
  • Take angamaheni
  • Wāhanga whakaora.
References Cellulitis 31747177 
NIH
Cellulitis he mate kiri bakiteria noa. Neke atu i te 14 miriona ngā tāngata e pā ana i ia tau i te United States. Ka tata ki te $3.7 piriona te utu mō te tiaki i ngā tūrarawa me te 650,000 ngā whare hōhipera i ia tau. Ko te tikanga, ka puta te cellulitis hei wāhi mahana, whero i runga i te kiri me te pupuhi me te ngāwari. Nā te mate bakiteria ohorere ka puta te mumura ki ngā papa kiri hohonu me ngā kiko tata. Kāore he puku, he nana rānei kei tēnei mate. Ko te Beta‑hemolytic streptococci, inā koa te rōpū A streptococcus (Streptococcus pyogenes), ko ngā kārihi o mua, ka whai ko methicillin‑sensitive Staphylococcus aureus.
Cellulitis is a common bacterial skin infection, with over 14 million cases occurring in the United States annually. It accounts for approximately 3.7 billion dollars in ambulatory care costs and 650000 hospitalizations annually. Cellulitis typically presents as a poorly demarcated, warm, erythematous area with associated edema and tenderness to palpation. It is an acute bacterial infection causing inflammation of the deep dermis and surrounding subcutaneous tissue. The infection is without an abscess or purulent discharge. Beta-hemolytic streptococci typically cause cellulitis, generally group A streptococcus (i.e., Streptococcus pyogenes), followed by methicillin-sensitive Staphylococcus aureus. Patients who are immunocompromised, colonized with methicillin-resistant Staphylococcus aureus, bitten by animals, or have comorbidities such as diabetes mellitus may become infected with other bacteria.
 Cellulitis: current insights into pathophysiology and clinical management 29219814
Ko te Cellulitis he mate huakita o te kiri me nga kopa ngohe. Ka puta ina he take ki te arai whakamarumaru o te kiri, te punaha aukati, te tohanga toto ranei. Ko te obesity (obesity), te leg swelling (leg swelling), me te old age (old age) ka piki ake te tupono o te cellulitis ma te pa ki enei waahi. Ka titiro ano matou ki nga kitenga o tata nei mo te whakamaaramatanga cellulitis, e whakaatu ana i te hiranga o te tātaritanga tika mai i te mea ko nga ahuatanga penei i te ngoikoretanga o te uaua, te eczema, te thrombosis uaua hohonu, me te kauti he maha tonu te pohehe ki te cellulitis. Ko nga patu paturopi e whakamahia ana ki te rongoa i te cellulitis ka ata whiriwhiria ki te aro ki nga huakita noa me te kore e akiaki i te aukati paturopi. Ka korero ano matou mo nga paturopi hou kua whakaaetia mo cellulitis. Cellulitis ka hoki mai ano na te mea kei te haere tonu nga ahuatanga morearea me te kino o te punaha lymphatic.
Cellulitis is a bacterial infection of the skin and soft tissues. It happens when there are issues with the skin's protective barrier, the immune system, or blood circulation. Diabetes, obesity, and old age increase the chances of cellulitis by affecting these areas. We also look at recent findings on diagnosing cellulitis, highlighting the importance of accurate diagnosis since conditions like venous insufficiency, eczema, deep vein thrombosis, and gout are often confused with cellulitis. Antibiotics used to treat cellulitis are chosen carefully to target common bacteria without encouraging antibiotic resistance. We also talk about new antibiotics approved for cellulitis. Cellulitis often comes back because of ongoing risk factors and damage to the lymphatic system..
 Current Treatment Options for Acute Skin and Skin-structure Infections 30957166 
NIH
He maha nga tangata ka haere ki nga hohipera, ki nga ruma ohorere ranei mo te Cellulitis (Cellulitis). Ko Staphylococcus aureus te iroriki matua e puta ai enei mate, a ka uaua haere te rongoa na te mea he atete etahi antibiotics (antibiotics) ki nga paturopi noa.
Acute bacterial skin and skin-structure infections are a common reason for seeking care at acute healthcare facilities, including emergency departments. Staphylococcus aureus is the most common organism associated with these infections, and the emergence of community-associated methicillin-resistant Staphylococcus aureus (MRSA) has represented a considerable challenge in their treatment.
 Prevalence and Therapies of Antibiotic-Resistance in Staphylococcus aureus 32257966 
NIH
Ka taea te wehea te Staphylococcus aureus kia rua nga momo i runga i ta raatau whakautu ki ngā paturopi: methicillin‑sensitive Staphylococcus aureus (MSSA), methicillin‑resistant Staphylococcus aureus (MRSA). I roto i ngā tekau tau kua pahure ake nei, nā te whanaketanga huakita me te nui o te whakamahinga o ngā patu paturopi, kua piki ake te aukati o te S. aureus ki ngā raau taero, ka piki ake te reiti mate MRSA ki te ao.
According to the sensitivity to antibiotic drugs, S. aureus can be divided into methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA). In recent decades, due to the evolution of bacteria and the abuse of antibiotics, the drug resistance of S. aureus has gradually increased, the infection rate of MRSA has increased worldwide.
 Treatment of severe skin and soft tissue infections: a review 29278528 
NIH
To review the salient features of the management of severe skin and soft tissue infections (SSTIs), including toxic shock syndrome, myonecrosis/gas gangrene, and necrotizing fasciitis.